Vascular Solutions
This article was originally published in The Gray Sheet
Executive Summary
Minneapolis firm acquires Angiosonics' Acolysis ultrasound-based system for treating total occlusions in peripheral vessels for $1.5 mil. in cash. The CE-marked product, composed of a generator and disposable intravascular probe, has had cumulative sales of over $2 mil. since 1998; the firm forecasts sales of approximately $1 mil. in 2003. U.S. clinical trials will begin shortly, and could take two to three years to complete...